Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Alnylam Pharmaceuticals, Inc. ALNY

Set alert

Price alert · ALNY

All alert types
158.00 USD -7.00 -4.24%

At close

158.63 +0.63 +0.40%

Pre-market · Nov 3, 6:41 AM ET

Bid
157.88 × 1
Ask
157.99 × 1
156.00 Day range 163.90
156.00 52-week range 479.79
YTD
-60.27%
1 year
-63.60%
Open
163.10
Prev close
165.00
Mkt cap
21.16B
Vol
4.76M
Avg vol
1.85M
EPS
19.80
P/E
7.98
Div yield
0.00%
More statistics
Low
156.00
High
163.90
Forward P/E
14.17
Beta
0.44
Short ratio
5.02
Inst. own
101.57%
Dividend
0.00
Ex-div date
Earnings
Feb 11, 2027
50-d avg
236.49
200-d avg
285.48
1y target
305.70

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 2, 2026Rating: Canaccord Genuity · Buy → Buy
  • Nov 2, 2026Downgrade: Truist Securities · Buy → Hold
  • Nov 2, 2026Rating: Barclays · Overweight → Overweight
Signals (82)
NameDateAgo
SMA: BearishJul 1, 20264 months ago
MACD: Sell SignalFeb 1, 20269 months ago
SMA: BearishJan 1, 202610 months ago
RSI: OverboughtJul 1, 20251 year ago
MACD: Buy SignalJul 1, 20242 years ago
SMA: BullishJun 1, 20242 years ago
SMA: BullishJun 1, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BearishSep 1, 20233 years ago
MACD: Sell SignalMay 1, 20233 years ago
SMA: BearishApr 1, 20233 years ago
MACD: Buy SignalSep 1, 20224 years ago
SMA: BullishAug 1, 20224 years ago
SMA: BullishAug 1, 20224 years ago
SMA: BearishApr 1, 20224 years ago
SMA: BullishFeb 1, 20224 years ago
SMA: BearishJan 1, 20224 years ago

Newest 20 of 82.

Analyst view

Consensus: buy

Buy
Price target (mean) 305.70 +93.5% upside
Target (low)
180.00
Target (mean)
305.70
Target (high)
455.00
Ratings (0m) 30 22 buy · 8 hold · 0 sell
  • Strong buy7
  • Buy15
  • Hold8
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 30
  • 1 month ago 29
  • 2 months ago 29

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ALNY analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter2.381.47 – 3.111.25+90.7%1.52B+38.6%13
Next quarter2.811.80 – 3.591.99+41.3%1.56B+33.2%8
Current year22.6721.55 – 24.715.08+346.3%5.44B+46.5%13
Next year11.368.74 – 17.7122.67-49.9%6.60B+21.2%17

Upgrades and downgrades

The latest rating changes

ALNY analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026BarclaysMaintainedOverweightOverweight
Nov 2, 2026Truist SecuritiesDowngradeBuyHold
Nov 2, 2026Canaccord GenuityMaintainedBuyBuy
Oct 30, 2026UBSMaintainedBuyBuy
Oct 30, 2026TD CowenMaintainedBuyBuy
Oct 30, 2026BernsteinDowngradeOutperformMarket Perform
Oct 30, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Oct 30, 2026Goldman SachsMaintainedBuyBuy
Oct 30, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Oct 30, 2026RBC CapitalMaintainedOutperformOutperform
Oct 30, 2026Raymond JamesDowngradeStrong BuyOutperform
Oct 29, 2026NeedhamMaintainedBuyBuy
Oct 14, 2026CitigroupMaintainedBuyBuy
Oct 14, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Sep 30, 2026JP MorganMaintainedOverweightOverweight
Sep 21, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 8, 2026JefferiesMaintainedHoldHold
Sep 2, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 19, 2026BMO CapitalInitiatedOutperformOutperform
Aug 14, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Aug 4, 2026Truist SecuritiesMaintainedBuyBuy
Aug 4, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 3, 2026Raymond JamesUpgradeOutperformStrong Buy
Aug 3, 2026CitigroupMaintainedBuyBuy
Aug 3, 2026BarclaysMaintainedOverweightOverweight
Jul 31, 2026JP MorganMaintainedOverweightOverweight
Jul 31, 2026RBC CapitalMaintainedOutperformOutperform
Jul 31, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jul 31, 2026OppenheimerMaintainedOutperformOutperform